Alpine Immune Sciences In... (ALPN)
NASDAQ: ALPN
· Real-Time Price · USD
64.97
0.01 (0.02%)
At close: May 17, 2024, 10:00 PM
Alpine Immune Sciences Revenue Breakdown
| Period Ending | Dec 31, 2023 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|
| Product Revenue | 762M | 23.4M | 7M |
| Product Revenue Growth | +3156.41% | +234.29% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 7.27M | 6.37M | 5.44M | 5.01M | 5.4M | 4.39M | 4.61M | 4.19M | 4.78M | 4.54M | 3.47M | 3.29M | 3.26M | 3.05M | 2.73M | 3.34M | 1.78M | 2.1M | 2.47M | 2.55M | 2.35M | 2.51M | 1.86M | 1.88M | 2.11M | 1.21M | 1.93M | 2.59M | 2.78M | 2.17M | 1.88M | 2.17M | 2.37M | 2.34M | 1.82M | 1.39M | 1.3M |
| Selling, General, and Administrative Revenue Growth | +14.07% | +17.10% | +8.71% | -7.24% | +22.99% | -4.79% | +9.92% | -12.17% | +5.08% | +30.95% | +5.47% | +1.04% | +6.79% | +11.77% | -18.42% | +88.08% | -15.41% | -14.80% | -3.37% | +8.87% | -6.72% | +35.38% | -1.38% | -10.67% | +74.65% | -37.53% | -25.46% | -6.80% | +28.27% | +15.38% | -13.49% | -8.24% | +1.28% | +28.27% | +31.36% | +6.82% | n/a |
| Research and Development Revenue | 22.46M | 22.78M | 19.15M | 19.24M | 19.58M | 18.76M | 17.59M | 17.59M | 16.31M | 15.36M | 18.31M | 14.63M | 10.44M | 9.05M | 6.16M | 7.1M | 4.88M | 5.8M | 9.53M | 10.17M | 10.35M | 8.93M | 10.53M | 5.72M | 3.79M | 3.71M | 2.75M | 359K | 2.76M | 5.66M | 5.67M | 6.42M | 5.57M | 4.29M | 4.28M | 4.46M | 3.02M |
| Research and Development Revenue Growth | -1.44% | +18.98% | -0.47% | -1.74% | +4.40% | +6.63% | +0.01% | +7.82% | +6.18% | -16.10% | +25.11% | +40.21% | +15.26% | +47.09% | -13.25% | +45.47% | -15.88% | -39.16% | -6.24% | -1.78% | +15.89% | -15.18% | +84.14% | +50.79% | +2.21% | +34.91% | +666.02% | -86.98% | -51.24% | -0.23% | -11.75% | +15.39% | +29.68% | +0.33% | -4.17% | +48.03% | n/a |